Blues ‘in talks to sign rising star’

first_imgChelsea are reportedly in talks to sign Lucas Moura, one of the rising stars of Brazilian football, who is understood to have a £66.8m release clause in his contract at Sao Paulo.AVB is keen on Hulk.The Daily Telegraph suggest Chelsea will not pay anywhere near that amount for the 19-year-old midfielder and are unlikely to table a bid before the transfer window closes, but may renew their interest during the summer.The Daily Mail report that Alex is close to completing his move to Paris St-Germain from Chelsea, whose owner Roman Abramovich has apparently blocked manager Andre Villas-Boas’ move for Porto striker Hulk after being quoted a world-record £83m.Willian has told The Sun he is desperate to leave Shakhtar Donetsk and sign for Chelsea.“Chelsea are known as one of the biggest and most successful clubs around,” said the Brazilian.“To play for them is a challenge I would accept and enjoy. If a deal doesn’t go through, I’ll understand. But I hope it happens.”French media yesterday reported that Nancy’s Mali international midfielder Samba Diakité is close to completing a loan move to QPR.Rangers boss Hughes has been linked with numerous players.The Mail pick up on this and add that Rangers are interested in Wigan’s Victor Moses.The Daily Mirror say QPR boss Mark Hughes is ready to launch a £4m bid for Moses’ Wigan’s team-mate Hugo Rodallega, whose contract expires at the end of the season. West Ham are also said to be interested.The Mirror also say QPR are monitoring Carlton Cole’s situation at West Ham and that Fulham are still interested in £7m-rated FC Twente winger Nacer Chadli.Finally, the Telegraph believe Anton Ferdinand will seek the advice of QPR chairman Tony Fernandes before deciding whether to shake John Terry’s hand before this weekend’s game against Chelsea.Follow West London Sport on TwitterFind us on Facebooklast_img read more

Continue Reading

Thinking Big About Big Data: GNS Tackles Personalized Healthcare

first_imgTop Reasons to Go With Managed WordPress Hosting Why Tech Companies Need Simpler Terms of Servic… 8 Best WordPress Hosting Solutions on the Market richard macmanus One of the top four trends identified in Rock Health’s report on digital health was data / analytics. Arguably, big data is the most important factor in transforming the healthcare system – given the vast amount of genetic and other medical data available today, combined with the increasing prevalence of mobile health apps and EMRs (Electronic Medical Records). One company thinking big about big data in healthcare is GNS Healthcare. The Cambridge, MA. firm has developed a large-scale technology platform that crunches huge data sets and delivers personalized medical recommendations.Big Data has been a trend in Internet technology in many markets, such as social networking, e-commerce and enterprise. But as GNS explains on its website, big data is particularly relevant in healthcare:“The healthcare industry is now awash in data: from biological data such as gene expression, SNPs, proteomics, metabolomics to, more recently, next-generation gene sequence data. This exponential growth in data is further fueled by the digitization of patient-level data: stored in Electronic Health Records (EHRs) and Health Information Exchanges (HIEs), enhanced with data from imaging and test results, medical and prescription claims, and personal health devices.”Delivering Personalized HealthcareGNS uses machine learning, run on “massively parallel cloud-based supercomputers,” to analyze all of this data and make use of it. Its core technology is called REFS (Reverse Engineering and Forward Simulation), which is explained in this video: A Web Developer’s New Best Friend is the AI Wai… Related Posts The overall goal of REFS is to help healthcare providers deliver “personalized medicine” to their patients. REFS uses a patient’s DNA, molecular and clinical data to try and ascertain what the best medicine is for that person.Real World DataColin Hill, the CEO and Chairman of GNS Healthcare’s parent company Via Science, recently wrote that the key to GNS’s approach is “real world data.” He defined that as “any data not generated from a randomized clinical trial (RCT).” Whereas RCT data comes from a controlled experiment, real world data is not controlled – but simply observed. It’s “everything from insurance claims and lab tests to patient registries and health IT systems.”Last August Hill told Metro Business Media his overall vision for personalized healthcare:“[My] vision is where data is collected and ultimately put into a centralized repository in the cloud where technology like ours will be mining the data continuously to determine what’s working and what’s not working for whom.”If you’re looking for the future of the Internet, it isn’t the next hot social video app. It’s software that aims to change people’s lives – perhaps even save lives. We’ll continue to track the progress of GNS. Tags:#health#web last_img read more

Continue Reading